Baird Medical swings to FY26 H1 net income of USD 13,499; revenue rises 24.6% to USD 9.92 million

• Baird Medical posted revenue of USD 9.92 million for the six months ended June 30, 2026, up 24.6%.
• Net income swung to USD 13,499 from a loss a year earlier, as operating income turned positive at USD 846,806.
• Gross margin widened 4.9 percentage points to 87% on shifts in geographic sales and revenue mix.
• Operating expenses fell to USD 7.78 million from higher levels a year earlier, on lower R&D and G&A, partly offset by higher selling costs.
• Management cited faster-than-planned U.S. commercial expansion; about 27% of first-half revenue came from the U.S. versus under 2% a year earlier.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baird Medical Investment Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609030800PRIMZONEFULLFEED9820913) on September 03, 2026, and is solely responsible for the information contained therein.